부산대학교 도서관

KEY TAKEAWAYS * The 2020 Focused Updates to the Asth ma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group provides updated recommendations for 6 topics related to the management of individuals with asthma. ** For the primary care clinician, key important updated recommendations relate to the use of intermittent inhaled corticosteroids, the use of long-acting muscarinic antagonists in the treatment of patients age [greater than or equal to] 12 years, and a more focused approach to indoor allergen mitigation. * The classification of asthma severity and asthma control, as well as the concept of utilizing a stepwise approach to pharmacologic treatment, were not updated from the Expert Panel Report 3, released in 2007. * However, important updates in preferred therapies for intermittent and persistent asthma at treatment steps 1 through 5 were suggested. * Recommendations regarding biologic therapy were not included in the 2020 update, as only evidence and US Food and Drug Administration approvals through October 2018 were considered. * The most recent 2021 Global Initiative for Asthma guidelines are not included in this review but can be used in a complementary manner to assist primary care clinicians to optimize decisions regarding the care of patients with asthma. FACULTY Kevin R. Murphy, MD, Director, Clinical Research, Allergy, Asthma and Pediatric Pulmonology, Boys Town National Research Hospital, Boys Town, Nebraska. Joel Solis, MD, Valley Medical Arts Clinic, The University of Texas Rio Grande Valley, McAllen, Texas. DISCLOSURES Dr. Murphy discloses that he serves on the advisory board and/or speakers bureau for AstraZeneca, Genentech, GlaxoSmithKline, Novartis, Regeneron, and Sanofi. Dr. Solis and Gregory Scott, PharmD, have no disclosures to report. ACKNOWLEDGMENT Editorial support was provided by Gregory Scott, PharmD, RPh, at the Primary Care Education Consortium. SPONSORSHIP This activity is sponsored by Primary Care Education Consortium and the Primary Care Respiratory Group and supported by funding from AstraZeneca Pharmaceuticals LP.
HISTORICAL OVERVIEW OF NATIONAL ASTHMA EDUCATION AND PREVENTION PROGRAM The National Heart, Lung, and Blood Institute (NHLBI) created the National Asthma Education and Prevention Program (NAEPP) in 1989 to address [...]